US20060281701A1 - Antisense antiviral compounds and methods for treating a filovirus infection - Google Patents

Antisense antiviral compounds and methods for treating a filovirus infection Download PDF

Info

Publication number
US20060281701A1
US20060281701A1 US11/433,840 US43384006A US2006281701A1 US 20060281701 A1 US20060281701 A1 US 20060281701A1 US 43384006 A US43384006 A US 43384006A US 2006281701 A1 US2006281701 A1 US 2006281701A1
Authority
US
United States
Prior art keywords
aug
compound
seq id
ebola
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/433,840
Other versions
US7507196B2 (en
Inventor
David Stein
Patrick Iversen
Sina Bavari
Dwight Weller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNITED STATES ARMY US ARMY MEDICAL RESEARCH AND MATERIAL COMMAND
US Secretary of Army
Sarepta Therapeutics Inc
Original Assignee
AVI BioPharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US62427704P priority Critical
Priority to US67169405P priority
Priority to US11/264,444 priority patent/US7524829B2/en
Application filed by AVI BioPharma Inc filed Critical AVI BioPharma Inc
Priority to US11/433,840 priority patent/US7507196B2/en
Assigned to AVI BIOPHARMA, INC. reassignment AVI BIOPHARMA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WELLER, DWIGHT D.
Publication of US20060281701A1 publication Critical patent/US20060281701A1/en
Priority claimed from ES13186973.7T external-priority patent/ES2645410T3/en
Assigned to UNITED STATES ARMY U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND reassignment UNITED STATES ARMY U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAVARI, SINA
Publication of US7507196B2 publication Critical patent/US7507196B2/en
Application granted granted Critical
Assigned to ARMY, UNITED STATES reassignment ARMY, UNITED STATES ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAVARI, SINA
Assigned to AVI BIOPHARMA, INC. reassignment AVI BIOPHARMA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IVERSEN, PATRICK L.
Assigned to AVI BIOPHARMA, INC. reassignment AVI BIOPHARMA, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ANTIVIRALS, INC.
Assigned to SAREPTA THERAPEUTICS, INC. reassignment SAREPTA THERAPEUTICS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AVI BIOPHARMA, INC.
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links